Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis

NCT03006146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Pulmonary Alveolar Proteinosis

Interventions

DRUG: Sargramostim

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]
[object Object]